James Heppell

James L.
Heppell is the founder of Sophiris Bio, Inc., founded in 2003, where the title held was Independent Director from 2003 to 2019.
Mr. Heppell was the founder of BC Advantage Funds Ltd., founded in 2005, where the title held was President & Director from 2012 to 2014.
Current jobs include Chairman & Chief Executive Officer at Emerald Health Sciences, Inc.; Chairman at PheroTech International, Inc.; Chairman at Emerald Health Therapeutics, Inc. since 2015; Chairman at Emerald Health Pharmaceuticals, Inc.; Director at Mobidia Technology, Inc.; Managing Director-Western Canada at Gold Medal Plates; Director at Emerald Health Bioceuticals, Inc. since 2015; Director at Verdélite Sciences, Inc.; Director at Pure Sunfarms Corp.; and Director at Verdélite Property Holdings, Inc. Former jobs include Chairman & Chief Executive Officer at Venturi Ventures, Inc. from 2010 to 2012; President, Chief Executive Officer & Partner at Catalyst Corporate Finance Lawyers from 1992 to 2006; Chairman at Inovio Pharmaceuticals, Inc.; Chairman-Securities Section at The Canadian Bar Association; Chairman at Contech Enterprises, Inc.; Director at Genetronics Biomedical Corp.; Director at Contigo Systems, Inc.; Director at Sirius Genomics, Inc.; Independent Director at Skye Bioscience, Inc.; President at Lions Capital Corp.; and Member-Corporate Finance Committee at LifeSciences British Columbia.
Education includes undergraduate and graduate degrees from the University of British Columbia.